Relay Therapeutics stock price
릴레이 테라퓨틱스NASDAQ:RLAY · Nasdaq · HealthcareToday's signals · MACD bullish cross
Signal details →Relay Therapeutics last closed at $18.96 (+2.54%) on 2026-10-02. Signals today: MACD bullish cross. Listed on Nasdaq. Trailing 12 months PER is -13.4×. Its overall grade ranks 166 of 739 stocks in Healthcare.
About this company
Relay Therapeutics last closed at $18.96 (+2.54%) on 2026-10-02. Signals today: MACD bullish cross. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall A- · 166/739
Valuation grade B+
Related stocks
- RocheCustomer
디그레이더/항암 신약 공동개발·라이선스 파트너로 연결
- GenentechCustomer
릴레이의 주요 항암 프로그램과 협업 이력으로 연결된 파트너
- PfizerCompetitor
표적항암·정밀의학 분야에서 신약 개발 경쟁
About Relay Therapeutics
- What technical signals does Relay Therapeutics (RLAY) have?
- Relay Therapeutics current technical signals: MACD bullish cross.
- Is Relay Therapeutics a cup-and-handle pattern?
- No. Relay Therapeutics has no valid Cup signal right now.
- What published figures are available for Relay Therapeutics?
- Market cap: $3.29B. Trailing 12 months PER: -13.4×. Latest quarter PBR: 4.32×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-03 dataset
Turn what you saw on this name into a strategy
Ask Q about Relay Therapeutics, or open the plan table on the main site.
From the names you found, through to a scheduled run
Set the conditions and they run at the scheduled time (live orders are not open yet).